Dialkylphenyl compounds having β
This invention relates to compounds of formula I: wherein R 1 and R 2 are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions and combinations comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compound to, for example, treat pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.
1. A compound of formula III:
wherein
Y 1 is selected from —CHO, —CN, —CH 2 OH, —CH(OR 3a )OR 3b , —C(O)OH, —C(O)OR 3c , bromo and iodo, where R 3a and R 3b are selected independently from C 1-6 alkyl, or R 3a and R 3b are joined to form C 2-6 alkylene, R 3c is selected from C 1-6 alkyl;
R 1 is methyl or ethyl;
R 2 is methyl or ethyl;
or a salt or stereoisomer thereof.
2. The compound of claim 1 , wherein R 1 and R 2 are methyl.
3. The compound of claim 1 , wherein Y 1 is —CHO.
4. The compound of claim 1 , wherein the compound has the formula:
or a salt thereof.
5. The compound of claim 1 , wherein the compound has the formula:
or a salt thereof.
6. The compound of claim 1 , wherein the compound has the formula:
or a salt thereof.
7. The compound of claim 1 , wherein the compound has the formula:
or a salt thereof.
8. The compound of claim 1 , wherein the compound has the formula:
or a salt thereof.